Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Phibro Animal Health (PAHC) EBT (2016 - 2026)

Phibro Animal Health has reported EBT over the past 14 years, most recently at $36.4 million for Q4 2025.

  • For Q4 2025, EBT rose 652.89% year-over-year to $36.4 million; the TTM value through Dec 2025 reached $126.2 million, up 273.59%, while the annual FY2025 figure was $68.0 million, 522.87% up from the prior year.
  • EBT for Q4 2025 was $36.4 million at Phibro Animal Health, roughly flat from $36.3 million in the prior quarter.
  • Over five years, EBT peaked at $36.4 million in Q4 2025 and troughed at -$12.0 million in Q3 2023.
  • A 5-year average of $14.2 million and a median of $12.2 million in 2022 define the central range for EBT.
  • Biggest five-year swings in EBT: crashed 321.14% in 2023 and later skyrocketed 652.89% in 2025.
  • Year by year, EBT stood at $23.5 million in 2021, then plummeted by 48.54% to $12.1 million in 2022, then tumbled by 70.56% to $3.6 million in 2023, then surged by 35.71% to $4.8 million in 2024, then skyrocketed by 652.89% to $36.4 million in 2025.
  • Business Quant data shows EBT for PAHC at $36.4 million in Q4 2025, $36.3 million in Q3 2025, and $23.8 million in Q2 2025.